Brachytherapy boosts RFA for lung cancer

The use of contrast-enhanced computed tomography (CECT) was associated with more than double the risk of contrast-induced acute kidney injury (CI-AKI) in patients with diabetes and an estimated glomerular filtration rate (eGFR) less than 30 mL/min/1.73 m2 in comparison to the use of non-contrast CT in this population.

Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.

In order to facilitate optimal detection and assessment of liver fibrosis and steatosis, the newly launched Hepatus 6 Diagnostic Ultrasound System offers the capabilities of real-time two-dimensional ultrasound with visual transient elastography in one device.

An interview with two experts to discuss newly released guidance for using standardized MRI protocols for patients with this condition.

Whether it’s attempting to get appropriate clinical histories from referring physicians or getting a tech to split up a multiphasic contrast study into separate image series, consistently striving to fight the good fight for optimal image interpretation is worth the effort.

For patients with residual or recurrent grade 2 isocitrate dehydrogenase (IDH)-mutant gliomas, magnetic resonance imaging (MRI) revealed that daily dosing of vorasidenib, an inhibitor of mutant IDH1 and IDH2 enzymes, led to a median progression-free survival of 27.7 months in comparison to 11.1 months in a placebo group, according to new research presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.